Summary & Overview
CPT 82128: Multi-Amino Acid Analysis in Clinical Specimens
CPT code 82128 designates a laboratory procedure for measuring multiple amino acids in specimens such as blood, plasma, urine, amniotic fluid, or cerebrospinal fluid. This panel-level amino acid analysis is clinically important for diagnosing inborn errors of metabolism, guiding biochemical genetic workups, and informing acute and chronic care pathways for affected patients. Nationally, amino acid testing plays a central role in newborn screening follow-up and in evaluating unexplained metabolic or neurologic symptoms across age groups.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on clinical indications and typical service settings, an overview of payer coverage considerations, and the operational aspects that influence billing and claims submission for amino acid panels. The publication outlines common modifiers and billing practices, summarizes service line placement within laboratory workflows, and highlights areas where payers commonly apply medical necessity criteria or prior authorization requirements.
The analysis provides benchmarks for utilization and reimbursement patterns, clarifies coding expectations for multi-specimen amino acid testing, and summarizes policy updates that affect laboratory service billing. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 82128 describes a laboratory test in which the analyst measures multiple amino acids in a clinical specimen. Typical specimens include blood, plasma, urine, amniotic fluid, or cerebrospinal fluid. The analysis is usually performed to detect the presence or abnormal levels of amino acids that are associated with inborn errors of metabolism or other metabolic disorders.
Service type: Laboratory — quantitative amino acid analysis
Typical site of service: Clinical laboratory or hospital laboratory; specimens may be collected in inpatient, outpatient, or neonatal settings
Clinical & Coding Specifications
Clinical Context
A newborn with poor feeding, vomiting, lethargy, and hypotonia is admitted to the neonatal unit on day 3 of life. The neonatologist orders metabolic screening due to concern for an inborn error of metabolism. A blood sample (plasma) and a urine specimen are sent to the clinical chemistry/molecular laboratory for amino acid analysis to detect abnormal concentrations or patterns suggestive of disorders such as phenylketonuria, maple syrup urine disease, homocystinuria, or organic acidemias. The laboratory technologist performs sample preparation, separation, and quantitation of multiple amino acids using techniques such as tandem mass spectrometry or ion-exchange chromatography. Results are reviewed by a pathologist or clinical chemist who issues a report; abnormal or critical values prompt immediate clinician notification and may trigger confirmatory testing, genetic consultation, dietary management, or transfer to a tertiary metabolic center. Typical site of service is the hospital laboratory or reference diagnostic laboratory supporting inpatient neonatal, pediatric, or outpatient metabolic evaluations.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation component if the laboratory charges are split between technical and professional components. |
TC |